SmithRx
PrivateLast Round
Series C
Jan 23, 2024
Est. Valuation
$100M
Total Funding Raised
$92M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SmithRx is a healthcare technology company that operates a pharmacy benefit manager platform designed to enhance transparency, efficiency, and data analytics in managing prescription benefits for employers and their members.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Pharma Supply Chain, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SmithRx Comparables
Compare SmithRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rightway | 84% | |
| EmpiRx Health | 83% | |
| Liviniti | 80% | |
SmithRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 23, 2024 | ||||
| Series B | Mar 10, 2022 | ||||
| Series A | Jan 11, 2018 | ||||
| Seed | Mar 31, 2017 |
Key People
Founding team and executive leadership
SmithRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blumberg Capital | Series A |
| Founders Fund | Series B, Series A |
| BoxGroup | Series A |
| Venrock | Series C, Series B |
| NextGen Venture Partners | Series A |
| NextGen Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 37% MoM to 46.7K.
- Apr 1, 2026
User base is doubling annually.
SmithRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SmithRx's valuation, stock price, and market status.